1. Broadhead CL, Betton G, Combes R, Damment S, Everett D, Garner C, Godsafe Z, Healing G, Heywood R, Jennings M, Lumley C, Oliver G, Smith D, Straughan D, Topham J, Wallis R, Wilson S, Buckley P (2000) Prospects for reducing and refining the use of dogs in the regulatory toxicity testing of pharmaceuticals. Hum Exp Toxicol 19:440
2. Casciano DA (1995) Progress since ICH 2. In: International conference on harmonization of technical requirements for registration of pharmaceuticals for human use (ICH 3 1995), Proceedings of the third international conference on harmonization, Yokohama, pp 205–211
3. Committee for Proprietary Medicinal Products (CPMP): Note for guidance on repeated dose toxicity CPMP/SWP/1042/99 corr., 27 July 2000
4. Contrera JF, Aub D, Barbehenn E, Belair E, Chen C, Evoniuk G, Mainigi K, Mielach F, Sancilio L (1993) A retrospective comparison of the results of 6 and 12 months non-rodent toxicity studies. Adverse Drug React Toxicol Rev 12(1):63–76
5. DeGeorge JJ, Meyers LL, Takahashi M, Contrera JF (1999) The duration of non-rodent toxicity studies for pharmaceuticals. Toxicol Sci 49:143–155